Latest News and Press Releases

Unyte Health marks 10 years as the leader of evidence-based listening therapies that support nervous system regulation, resilience, and mind-body wellness.

MAPS brings MDMA-assisted therapy training to Poland for the first time, awarding scholarships to 20 practitioners from war-affected Ukraine and Palestine.

Backed by Sam Altman, Fred Ehrsam, and Dylan Field, Arcadia Medicine is accelerating development of safe empathogens via patented, non-racemic MDMA

PharmAla completes first domestic US shipment of MDMA from its new domestic distribution center, and issues shares as debt payment.

ATMA CENA announce the expansion of its psychedelic therapy clinic network to 13 locations across Canada

Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health

ORLANDO, Fla., Sept. 17, 2025 (GLOBE NEWSWIRE) -- It is estimated that more than 13 million Americans struggle with post-traumatic stress disorder (PTSD). A new study, Hyperbaric Oxygen Therapy for...

SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company,...

MAPS selects Changemark as CRO for $12.9M Phase 2 cannabis PTSD study in Veterans, advancing toward Q1 2026 treatment start.

PharmAla delivers over 500 LaNeo MDMA capsules to Merhavim Psychiatric Hospital to be used in a clinical trial in exchange for IP rights to trial results